Mind Games: The Future of an Alzheimer’s Treatment and Why It’s So Controversial (Podcast)
FDA Adviser Dr. Caleb Alexander of John’s Hopkins talks about Aducanumab/Aduhelm: a groundbreaking Alzheimer’s treatment sent to market in one of the most controversial FDA approvals ever.
Continue reading Mind Games: The Future of an Alzheimer’s Treatment and Why It’s So Controversial (Podcast) on sharylattkisson.com.
